Intelligence Β· Clinical Pipeline

IONIS PHARMACEUTICALS Pipeline

All ClinicalTrials.gov programs at IONIS PHARMACEUTICALS β€” phase, modality, and trial IDs.

Programs
63

Quick answer

IONIS PHARMACEUTICALS has 63 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. ISIS-APOCIIIRX

    IONIS PHARMACEUTICALS INC

    Type 2 Diabetes

    phase 2 small molecule terminated

    1 trial
  2. ISIS-FGFR4RX

    IONIS PHARMACEUTICALS INC

    Obesity

    phase 2 small molecule completed

    1 trial
  3. ISIS-FXIRx Dose #2

    IONIS PHARMACEUTICALS INC

    Venous Thromboembolism

    phase 2 small molecule completed

    1 trial
  4. ISIS-GCCRRx

    IONIS PHARMACEUTICALS INC

    Type 2 Diabetes Mellitus

    phase 2 small molecule completed

    1 trial
  5. ISIS-GCGRRx

    IONIS PHARMACEUTICALS INC

    Type 2 Diabetes

    phase 2 small molecule completed

    1 trial
  6. ISIS-GCGRRx - Dose Level 1

    IONIS PHARMACEUTICALS INC

    Type 2 Diabetes Mellitus

    phase 2 small molecule completed

    1 trial
  7. ISIS-GCGRRx- Dose Level 1

    IONIS PHARMACEUTICALS INC

    Type 2 Diabetes

    phase 2 small molecule completed

    1 trial
  8. ISIS-PTP1BRx

    IONIS PHARMACEUTICALS INC

    Type 2 Diabetes Mellitus

    phase 2 small molecule completed

    1 trial
  9. Isis 420915/GSK 299872

    IONIS PHARMACEUTICALS INC

    Amyloidosis

    phase 2 small molecule terminated

    1 trial
  10. Placebo

    IONIS PHARMACEUTICALS INC

    Hypertension

    phase 2 small molecule completed

    2 trials
  11. Placebo

    IONIS PHARMACEUTICALS INC

    Mild Hypertension

    phase 2 small molecule completed

    1 trial
  12. Placebo

    IONIS PHARMACEUTICALS INC

    NAFLD

    phase 2 small molecule completed

    1 trial
  13. mipomersen

    IONIS PHARMACEUTICALS INC

    Metabolic Diseases

    phase 2 small molecule completed

    1 trial
  14. sapablursen

    IONIS PHARMACEUTICALS INC

    Phlebotomy Dependent Polycythemia Vera

    phase 2 small molecule active

    1 trial
  15. sapablursen

    IONIS PHARMACEUTICALS INC

    Beta Thalassemia Intermedia

    phase 2 small molecule terminated

    1 trial

Frequently asked questions

How many pipeline programs does IONIS PHARMACEUTICALS have?

63 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources Β· All pipeline programs